Conditions: Leukemia Cutis; Myeloid Sarcoma; Untreated Adult Acute Myeloid Leukemia; Untreated Childhood Myeloid Neoplasm Interventions: Drug: Asparaginase; Drug: Bortezomib; Drug: Cytarabine; Drug: Daunorubicin Hydrochloride; Drug: Etoposide; Other: Laboratory Biomarker Analysis; Drug: Mitoxantrone Hydrochloride; Other: Pharmacological Study; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Drug: Sorafenib Tosylate
Principal Investigator:
Shen, Violet
Research Coordinator:
Kathryn Duvall
(714) 509-8646
Visit clinicaltrials.gov for more information about this trial.
- IRB Number: 110771
- Sponsor: COG
- Protocol Number: AAML1031
- NCT Number: NCT01371981
- Research Type: Leukemia/Lymphoma
- Phase: III
- Status: Active - Closed to Enrollment